Susquehanna Fundamental Investments, LLC Cure Vac N.V. Transaction History

Susquehanna Fundamental Investments, LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 11, 2021	SELL	$56.91 - $127.53 $1.03 Million - $2.31 Million	-18,100 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$43.8 - $77.2 $792,780 - $1.4 Million	18,100 New	18,100 $843,000

14.4M

241K

419K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $645M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.